IRF8 and neoplasm: Tumor‐derived prostaglandin E2 (PGE2) plays a significant immunosuppressive role by inducing cDC1 dysfunction through EP2/EP4‐mediated cAMP signaling, which downregulates the transcription factor IRF8, critical for cDC1 function and antitumor immunity [74].